Zolinza
Generic name: Vorinostat
Drug class:
Histone deacetylase inhibitors
Usage of Zolinza
Zolinza is a prescription medicine used to treat skin problems caused by cutaneous T-cell lymphoma.
Zolinza is usually given after other treatments did not work or have stopped working, or your cutaneous T-cell lymphoma gets worse or comes back after you have taken other medicines.
It is not known if Zolinza is safe and effective in children.
Zolinza side effects
Get emergency medical help if you have signs of an allergic reaction to Zolinza: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Zolinza side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Zolinza
To make sure Zolinza is safe for you, tell your doctor if you have:
Vorinostat can harm an unborn baby if the mother or the father is using this medicine.
Do not breast-feed while using this medicine, and for at least 1 week after your last dose.
Relate drugs
How to use Zolinza
Usual Adult Dose for Cutaneous T-cell Lymphoma:
400 mg orally once a day; If a patient is intolerant to therapy, the dose may be reduced to 300 mg orally once daily; the dose may be further reduced to 300 mg once daily for 5 consecutive days each week if needed -This drug should be taken with food. -Swallow capsules whole; do not open or crush. -Therapy may be continued as long as there is no evidence of progressive disease or unacceptable toxicity. Use: For the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent, or recurrent disease on or following 2 systemic therapies
Warnings
You should not use Zolinza if you are allergic to vorinostat, or if you have severe liver disease.
Do not use Zolinza if you are pregnant. It could harm the unborn baby.
You should not breast-feed while you are using Zolinza.
Drink at least 2 liters of water each day to keep from getting dehydrated while you are taking Zolinza. Tell your doctor if you have severe vomiting or diarrhea during treatment.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.Do not crush or open a Zolinza capsule. Swallow it whole. The medicine inside the capsule can be dangerous if it gets in your eyes, mouth, or nose, or on your skin. If this occurs, wash your skin with soap and water or rinse your eyes with water. Ask your doctor or pharmacist how to safely handle and dispose of a broken tablet or capsule.
Stop using Zolinza and call your doctor at once if you have chest pain, sudden cough, wheezing, rapid breathing, coughing up blood, swelling or warmth in one or both legs, fever, chills, mouth sores, easy bruising or bleeding, bloody or tarry tools, or severe vomiting or diarrhea.
What other drugs will affect Zolinza
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with vorinostat, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions